Serratus Anterior Plane and PECS II Blocks After Coronary Artery Bypass Grafting
Postoperative Bilateral Serratus Anterior Plane Versus PECS II Block in Intubated Patients Undergoing Elective Coronary Artery Bypass Grafting: A Prospective, Randomized, Placebo-Controlled Trial
1 other identifier
interventional
243
1 country
1
Brief Summary
This prospective randomized placebo-controlled trial was designed to evaluate the effects of ultrasound-guided bilateral pectoralis (PECS II) and serratus anterior plane (SAP) blocks on postoperative recovery in adult patients undergoing elective coronary artery bypass grafting (CABG). Patients were randomized to receive bilateral PECS II block, bilateral SAP block, or bilateral sham fascial plane injections in addition to standardized systemic analgesia. The study evaluated postoperative pain intensity using the Visual Analog Scale (VAS), opioid consumption, postoperative nausea and vomiting (PONV), block-related complications, duration of mechanical ventilation, time to first mobilization, and intensive care unit (ICU) length of stay.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable postoperative-pain
Started Dec 2022
Typical duration for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 5, 2022
CompletedFirst Submitted
Initial submission to the registry
May 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 5, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2024
CompletedFirst Posted
Study publicly available on registry
January 27, 2025
CompletedAugust 6, 2026
August 1, 2026
1 year
May 17, 2023
August 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative pain intensity assessed using the Visual Analog Scale (VAS)
Postoperative pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity. Assessments will be performed at 4, 8, 12, and 24 hours after extubation.
4, 8, 12, and 24 hours after extubation
Secondary Outcomes (6)
Postoperative nausea and vomiting (PONV)
Within 24 hours after surgery
Block-related complications
During hospitalization
Length of intensive care unit (ICU) stay
From ICU admission to ICU discharge (assessed up to 30 days).
Time to first mobilization
From ICU admission to first mobilization (assessed up to 7 days).
Duration of mechanical ventilation
From ICU admission to successful extubation (assessed up to 7 days).
- +1 more secondary outcomes
Study Arms (3)
Bilateral SAP Block
EXPERIMENTALParticipants undergoing elective coronary artery bypass grafting received an ultrasound-guided bilateral serratus anterior plane (SAP) block using 20 mL of 0.25% bupivacaine on each side. To maintain study blinding, ultrasound-guided placebo injections consisting of 20 mL of 0.9% saline were also administered bilaterally at the PECS II injection sites using identical coded syringes.
Bilateral PECS II Block
ACTIVE COMPARATORParticipants undergoing elective coronary artery bypass grafting received an ultrasound-guided bilateral PECS II block using 20 mL of 0.25% bupivacaine on each side. To maintain study blinding, ultrasound-guided placebo injections consisting of 20 mL of 0.9% saline were also administered bilaterally at the serratus anterior plane injection sites using identical coded syringes.
Sham Block
PLACEBO COMPARATORParticipants undergoing elective coronary artery bypass grafting received ultrasound-guided bilateral placebo injections consisting of 20 mL of 0.9% saline on each side at both the PECS II and serratus anterior plane injection sites using identical coded syringes to maintain study blinding. All participants received the same standardized postoperative systemic analgesic regimen.
Interventions
Ultrasound-guided bilateral serratus anterior plane (SAP) block performed using 20 mL of 0.25% bupivacaine on each side after ICU admission while patients remained intubated following elective coronary artery bypass grafting.
Ultrasound-guided bilateral PECS II block was performed using the standard two-injection technique after ICU admission while patients remained intubated following elective coronary artery bypass grafting. On each side, a total of 20 mL of 0.25% bupivacaine was injected between the pectoralis major and minor muscles and between the pectoralis minor and serratus anterior muscles.
Ultrasound-guided bilateral sham fascial plane procedure was performed after ICU admission while patients remained intubated following elective coronary artery bypass grafting. On each side, 20 mL of 0.9% saline was injected at both the PECS II and serratus anterior plane injection sites using identical coded syringes to maintain study blinding.
Eligibility Criteria
You may qualify if:
- Adults aged 20 years and older ASA physical status II-IV Scheduled for elective coronary artery bypass grafting (CABG) via median sternotomy Extubated in the intensive care unit after surgery Provided written informed consent
You may not qualify if:
- Refusal to participate or inability to provide informed consent Pregnancy Known allergy or contraindication to bupivacaine or other amide local anesthetics Coagulopathy or ongoing anticoagulation precluding regional anesthesia Local infection at the planned injection site Severe hepatic or renal failure Pre-existing chronic opioid use or chronic pain requiring opioid treatment Pre-existing neurological disorders affecting pain assessment Requirement for emergency surgery or concomitant cardiac procedures other than isolated CABG Reoperation for postoperative bleeding before outcome assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Van Yuzuncu Yil University Faculty of Medicine Department of anesthesiology and reanimation
Van, Tuşba, 65080, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
School of Mdicine Department of Anesthesiology and Reanimation
Yuzuncu Yil University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The allocation sequence and coded syringes were prepared by an investigator who was not involved in intervention administration, postoperative care, or outcome assessment. Each participant had two identical-appearing syringes labelled "PECS" and "SAP." The active syringe contained bupivacaine and the other contained 0.9% saline; both syringes contained saline in the sham group. A blinded anesthesiologist performed ultrasound-guided injections in both anatomical regions for every participant and was unaware of syringe contents and allocation. Participants, ICU clinicians responsible for postoperative care, ventilator weaning and extubation, and postoperative outcome assessors were blinded. Only the investigator preparing the syringes had access to the allocation sequence.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 17, 2023
First Posted
January 27, 2025
Study Start
December 5, 2022
Primary Completion
December 5, 2023
Study Completion
January 31, 2024
Last Updated
August 6, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
No individual participant data (IPD) will be shared with other researchers.